InvestorsHub Logo
Followers 1
Posts 57
Boards Moderated 0
Alias Born 02/05/2018

Re: None

Monday, 08/20/2018 12:26:52 PM

Monday, August 20, 2018 12:26:52 PM

Post# of 6606
NEW YORK, NY / ACCESSWIRE / August 20, 2018 / Ekso Bionics (NASDAQ: EKSO) has been on a tear this month, rising 60% since their second-quarter earnings announcement after being stuck in sideways action for months, while no one seemed to care.

Ekso Bionics (EKSO) shares traded from$1.80 to $3.00 in the past 30 days based on commercial success and the potential for a substantial bump in revenue soon. Investors recently long EKSO have made 65% with more potential upside to come.

First, Ekso reported encouraging revenues of $3 million in the quarter, up 59% from the same period one year ago, and Ford Motor Company (F) has committed to expanding an initial pilot program for their EksoVest at 15 of their assembly plants in seven countries. Second, it's rumored that the company may have secured a $5 million contract from the Department of Veterans Affairs setting up a major potential "catalyst" for EKSO if this deal is announced in a press release. And finally, EKSO was primed for a technical breakout to the upside after a period of sideways trading almost all of 2018, with $2.00 acting as resistance for the shares repeatedly.

With this move, the technicals and the fundamentals were aligned; major overhang sellers have finally disappeared, and EKSO was off to the races.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News